STOCK TITAN

Uipath Inc SEC Filings

PATH NYSE

Welcome to our dedicated page for Uipath SEC filings (Ticker: PATH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

UiPath SEC filings document material events for an enterprise automation software company listed under PATH. Recent Form 8-K disclosures cover operating and financial results, executive leadership and compensation arrangements, annual meeting voting outcomes, and governance matters including director elections, advisory compensation votes, and auditor ratification.

The filings also record capital-structure subjects tied to UiPath's Class A and Class B common stock, including stockholder trading-plan disclosures. These records frame PATH's public-company reporting around results releases, board and officer matters, stockholder votes, and equity ownership structure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (PATH) Form 4 filing: Director Philippe Botteri received an annual grant of 16,064 Restricted Stock Units (RSUs) on 26 Jun 2025 under the company’s non-employee director compensation policy. Each RSU converts into one Class A share when vested. The award vests on the earlier of the next annual meeting or the first anniversary of the grant date, provided the director remains in service.

The RSUs were issued at a price of $0.00, so no cash changed hands and no open-market transaction occurred. Following the grant, Botteri’s beneficial ownership rises to 3,160,889 Class A shares. No derivative securities or additional transactions were reported. The filing contains no other material corporate developments or financial metrics and is considered routine, with negligible dilution relative to UiPath’s total share count.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

UiPath (NYSE:PATH) CEO, Chairman and 10% owner Daniel Dines filed a routine Form 4 reporting the sale of 45,000 Class A shares on 06/27/2025 at an average price of $12.78 under a Rule 10b5-1 trading plan, for proceeds of roughly $0.58 million.

Dines still beneficially owns about 30.8 million shares: 24.9 million directly, 5.6 million through Ice Vulcan Holding Ltd., and 240,000 held by his spouse. The sale represents less than 0.2% of his holdings and does not affect his control position. No derivative securities were involved, and no other material changes were disclosed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath (NYSE:PATH) filed a Form 4 disclosing that CEO, Chairman and 10% owner Daniel Dines sold 45,000 Class A shares on 26 Jun 2025 at an average price of $12.38, generating about $0.56 million. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

After the sale, Dines still beneficially owns roughly 30.8 million shares (direct, indirect and spouse holdings), so the disposal represents well under 1% of his position. No other transactions or derivative movements were reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UiPath (NYSE:PATH) filed a Form 4 showing CEO-Chairman Daniel Dines sold 45,000 Class A shares on 25 Jun 2025 at an average $12.55 under a Rule 10b5-1 plan. Post-sale, he still controls roughly 30.8 million shares, so the transaction equals <0.2% of his holdings and ≈$0.56 million in value—below materiality thresholds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.32%
Tags
insider
-
Rhea-AI Summary

UiPath CEO and Chairman Daniel Dines reported a significant insider transaction on June 24, 2025, selling 45,000 shares of Class A Common Stock at an average price of $12.4876 per share (ranging from $12.4150 to $12.5500). The transaction was executed through a pre-planned 10b5-1 trading plan.

Following the transaction, Dines maintains substantial holdings in UiPath:

  • 24,918,585 shares held directly
  • 5,733,376 shares held indirectly through Ice Vulcan Holding Limited
  • 240,000 shares held indirectly through spouse

As a Director, CEO, Chairman, and 10% Owner, Dines maintains significant control over the company. The shares held through Ice Vulcan Holding Limited are controlled by Dines through a corporate structure where he retains sole voting and investment power.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 23, 2025, at an average price of $12.096 per share through a pre-planned 10b5-1 trading plan.

Following the transaction, Dines maintains significant ownership positions:

  • 24,918,585 shares held directly
  • 5,778,376 shares held indirectly through Ice Vulcan Holding Limited
  • 240,000 shares held indirectly through spouse

The sale was executed through a qualified Rule 10b5-1 trading plan, with transaction prices ranging from $12.00 to $12.24. Dines serves multiple roles at UiPath including Director, CEO, Chairman, and qualifies as a 10% owner. The transaction was reported via Form 4 filed through his attorney-in-fact, Brad Brubaker.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

A Form 144 filing reveals that UiPath (NYSE: PATH) has reported a proposed sale of 1,000,000 shares of common stock with an aggregate market value of $12.37 million. The sale is to be executed through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of June 20, 2025.

The securities were originally acquired as Founders Shares from the issuer on April 21, 2021. The filing also discloses significant recent trading activity by ICE VULCAN HOLDING LIMITED through a 10b5-1 trading plan, with:

  • Regular sales of 45,000 shares per transaction over the past three months
  • Total sales of approximately 969,879 shares between May-June 2025
  • Sale prices ranging from $11.80 to $13.31 per share

This planned sale represents approximately 0.22% of UiPath's total outstanding shares of 457,586,105.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Uipath (PATH) SEC filings are available on StockTitan?

StockTitan tracks 175 SEC filings for Uipath (PATH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Uipath (PATH)?

The most recent SEC filing for Uipath (PATH) was filed on July 1, 2025.